New fund injected into portfolio, bought 7500 shares of Supermx at RM1.85. The new investment result in the glove-companies forming ~28% weight in my whole portfolio now.
a glance of Supermax's historical data:
Supermx is expanding its surgical glove capacity since 2012. According to the management's plan, the nitrile capacity of Supermx will soon be doubled when its new plants are commissioned by next year. This will cause nitrile-glove forming ~50% of the company's total output.
This change in product portfolio will deliver a better profit margin, hence great potential of profit growth in near future. It's expansion of distribution business in US and Canada will also position the group to secure greater share in these markets.
.
a glance of Supermax's historical data:
| RM Million | |||
| Revenue | PBT | PAT | |
| 2003 | 131.2 | 20.0 | 17.4 |
| 2004 | 218.4 | 34.3 | 30.2 |
| 2005 | 284.7 | 39.9 | 36.3 |
| 2006 | 400.3 | 47.3 | 39.8 |
| 2007 | 574.3 | 58.6 | 55.9 |
| 2008 | 811.8 | 52.0 | 47.0 |
| 2009 | 803.6 | 151.5 | 126.6 |
| 2010 | 977.3 | 183.8 | 159.0 |
| 2011 | 1,021.4 | 112.1 | 104.1 |
| 2012 | 1,048.4 | 140.2 | 121.5 |
Supermx is expanding its surgical glove capacity since 2012. According to the management's plan, the nitrile capacity of Supermx will soon be doubled when its new plants are commissioned by next year. This will cause nitrile-glove forming ~50% of the company's total output.
This change in product portfolio will deliver a better profit margin, hence great potential of profit growth in near future. It's expansion of distribution business in US and Canada will also position the group to secure greater share in these markets.
.
